2024 U.S. Hospital Hemostasis Diagnostics Marke: Supplier Shares and Sales Segment Forecasts

This new report contains 411 pages, 28 tables. The report is available by section, and can be customized to specific information needs and budget. The report presents a comprehensive analysis of the US hospital hemostasis diagnostic testing market, including: 

  • Major issues pertaining to the US hospital coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. 
  • Volume and sales forecasts for 40 coagulation procedures performed in US hospitals, including typical coagulation daily work loads. 
  • Review of current instrumentation technologies, and a feature comparison of leading analyzers. 
  • Reagent and instrument sales forecasts. 
  • Sales and market shares of leading reagent and instrument suppliers. 
  • Review of coagulation technologies and their potential market applications. 
  • Major opportunities for new coagulation instruments and consumables. 
  • Profiles of  major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • Business opportunities and strategic recommendations for instrument and reagent suppliers. 

        


I. Introduction
II. Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests

20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrands Factor
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their
Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Molecular Diagnostics
5. Microcomputers
6. Automation
7. Robotics
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
III. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument
and Reagent Suppliers Sales and Market Shares
IV. Major Product Development Opportunities
V. Design Criteria For Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
The report provides strategic assessments of over 20 leading coagulation
market players and start-up companies with innovative technologies and
products, including:
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Diagnostica Stago
Grifols
Helena Laboratories
IL/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex
Thermo Fisher, and others

List Of Tables


Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation
Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator
Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests

Major Companies Developing or Marketing Von Willebrands
Factor Tests
Executive Summary Table: U.S.A., Hospital Coagulation Diagnostics
Market By Product Category
U.S.A., Hospital Laboratories Performing Coagulation Tests
By Bed Size
U.S.A., Hospital Laboratories Average Daily Test Volume
U.S.A., Hospital Laboratories Coagulation Test Volume by Assay
U.S.A., Major Suppliers of Coagulation Reagents,
Estimated Sales and Market Shares
U.S.A., Major Suppliers of Coagulation Analyzers,
Estimated Sales and Market Shares
U.S.A., Coagulation Diagnostics Market By Product Category
U.S.A., Major Suppliers of Coagulation Diagnostic Products,
Estimated Sales and Market Shares

Global Vitamin D Market Research Report 2020-2024

In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Vitamin D Report by Material, Application, and Geography Global Forecast

USD 2850 View Report

2020 What’s Driving the Healthcare Industry?--The Road to 2024 and Beyond

The series includes current assessments of more than 1,000 companies worldwide. Depending on the companys business nature and structure, the assessments include all or some of the following analyses: Organization

USD 4500 View Report

2024 U.S. Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

This new 1,157-page report contains 65 tables.The report is available by section, and can be customized to specific information needs and budget. The report presents a comprehensive analysis of the

USD 3850 View Report

2024 U.S. Virology and Bacteriology Market for over 100 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation, Opportunities

This new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.The report is available by section, and can

USD 3850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available